Beyond Air, Inc. Basic Shares Outstanding (Weighted Average)
Beyond Air, Inc. (XAIR) reported Basic Shares Outstanding (Weighted Average) of 721.33 thousand shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-13
- Beyond Air, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 721.33K shares, a 187.67% increase year-over-year.
- Beyond Air, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 13.20M shares, a 194.67% increase year-over-year.
- Beyond Air, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 8.62M shares, a 95.67% increase year-over-year.
- Beyond Air, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 6.36M shares, a 169.81% increase year-over-year.
- Beyond Air, Inc. weighted average number of shares outstanding, basic for fiscal 2026 was 8.30M shares, a 145.20% increase from fiscal 2025.
- Beyond Air, Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 3.39M shares, a 89.79% decline from fiscal 2024.
- Beyond Air, Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 33.16M shares, a 10.63% increase from fiscal 2023.
- Beyond Air, Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 29.97M shares, a 16.77% increase from fiscal 2022.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 721.33K shares 10-Q · filed 2026-08-13 | 6.96M shares derived: average of 2 quarters · filed 2026-08-13 | 7.51M shares derived: average of 3 quarters · filed 2026-08-13 | 7.22M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | 13.20M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-26 | 10.91M shares derived: average of 2 quarters · filed 2026-06-26 | 9.39M shares derived: average of 3 quarters · filed 2026-06-26 | 8.30M shares 10-K · filed 2026-06-26 | ||||
| 2025-12-31 | 8.62M shares 10-Q · filed 2026-02-13 | 7.49M shares derived: average of 2 quarters · filed 2026-02-13 | 6.67M shares 10-Q · filed 2026-02-13 | 4.93M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2025-09-30 | 6.36M shares 10-Q · filed 2025-11-10 | 5.69M shares 10-Q · filed 2025-11-10 | 3.70M shares derived: average of 3 quarters · filed 2026-08-13 | 3.87M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | 250.75K shares 10-Q · filed 2026-08-13 | 5.01M shares 10-Q · filed 2025-08-12 | 2.36M shares derived: average of 2 quarters · filed 2026-08-13 | 3.04M shares derived: average of 3 quarters · filed 2026-08-13 | 2.87M shares derived: average of 4 quarters · filed 2026-08-13 | |||
| 2025-03-31 | 4.48M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-26 | 4.44M shares derived: average of 2 quarters · filed 2026-06-26 | 3.75M shares derived: average of 3 quarters · filed 2026-06-26 | 3.39M shares 10-K · filed 2026-06-26 | 67.71M shares 10-K · filed 2025-06-20 | |||
| 2024-12-31 | 4.40M shares 10-Q · filed 2026-02-13 | 88.07M shares 10-Q · filed 2025-02-10 | 3.38M shares derived: average of 2 quarters · filed 2026-02-13 | 3.02M shares 10-Q · filed 2026-02-13 | 60.42M shares 10-Q · filed 2025-02-10 | 11.51M shares derived: average of 4 quarters · filed 2026-02-13 | ||
| 2024-09-30 | 2.36M shares 10-Q · filed 2025-11-10 | 47.12M shares 10-Q · filed 2024-11-12 | 2.33M shares 10-Q · filed 2025-11-10 | 46.51M shares 10-Q · filed 2024-11-12 | 13.88M shares derived: average of 3 quarters · filed 2025-11-10 | 18.53M shares derived: average of 4 quarters · filed 2025-11-10 | ||
| 2024-06-30 | 2.30M shares 10-Q · filed 2025-08-12 | 45.90M shares 10-Q · filed 2024-08-06 | 19.64M shares derived: average of 2 quarters · filed 2025-08-12 | 23.92M shares derived: average of 3 quarters · filed 2025-08-12 | 25.89M shares derived: average of 4 quarters · filed 2025-08-12 | |||
| 2024-03-31 | 36.99M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-06-20 | 34.73M shares derived: average of 2 quarters · filed 2025-06-20 | 33.75M shares derived: average of 3 quarters · filed 2025-06-20 | 33.16M shares 10-K · filed 2025-06-20 | ||||
| 2023-12-31 | 32.46M shares 10-Q · filed 2025-02-10 | 32.13M shares derived: average of 2 quarters · filed 2025-02-10 | 31.88M shares 10-Q · filed 2025-02-10 | 31.46M shares derived: average of 4 quarters · filed 2025-02-10 | ||||
| 2023-09-30 | 31.80M shares 10-Q · filed 2024-11-12 | 31.59M shares 10-Q · filed 2024-11-12 | 31.12M shares derived: average of 3 quarters · filed 2024-11-12 | 30.82M shares derived: average of 4 quarters · filed 2024-11-12 | ||||
| 2023-06-30 | 31.38M shares 10-Q · filed 2024-08-06 | 30.78M shares derived: average of 2 quarters · filed 2024-08-06 | 30.50M shares derived: average of 3 quarters · filed 2024-08-06 | 30.35M shares derived: average of 4 quarters · filed 2024-08-06 | ||||
| 2023-03-31 | 30.19M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-06-24 | 30.05M shares derived: average of 2 quarters · filed 2024-06-24 | 30.00M shares derived: average of 3 quarters · filed 2024-06-24 | 29.97M shares 10-K · filed 2024-06-24 | ||||
| 2022-12-31 | 29.92M shares 10-Q · filed 2024-02-12 | 29.91M shares derived: average of 2 quarters · filed 2024-02-12 | 29.90M shares 10-Q · filed 2024-02-12 | 29.86M shares derived: average of 4 quarters · filed 2024-02-12 | ||||
| 2022-09-30 | 29.90M shares 10-Q · filed 2023-11-13 | 29.89M shares 10-Q · filed 2023-11-13 | 29.83M shares derived: average of 3 quarters · filed 2023-11-13 | 29.08M shares derived: average of 4 quarters · filed 2023-11-13 | ||||
| 2022-06-30 | 29.89M shares 10-Q · filed 2023-08-10 | 29.80M shares derived: average of 2 quarters · filed 2023-08-10 | 28.81M shares derived: average of 3 quarters · filed 2023-08-10 | 27.65M shares derived: average of 4 quarters · filed 2023-08-10 | ||||
| 2022-03-31 | 29.71M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-06-22 | 28.27M shares derived: average of 2 quarters · filed 2023-06-22 | 26.90M shares derived: average of 3 quarters · filed 2023-06-22 | 25.67M shares 10-K · filed 2023-06-22 | 25.67B shares 10-K · filed 2022-06-29 | |||
| 2021-12-31 | 26.82M shares 10-Q · filed 2023-02-10 | 25.49M shares derived: average of 2 quarters · filed 2023-02-10 | 24.32M shares 10-Q · filed 2023-02-10 | |||||
| 2021-09-30 | 24.17M shares 10-Q · filed 2022-11-08 | 23.06M shares 10-Q · filed 2022-11-08 | ||||||
| 2021-06-30 | 21.95M shares 10-Q · filed 2022-08-11 | |||||||
| 2021-03-31 | 18.01B shares 10-K · filed 2022-06-29 | |||||||
| 2019-03-31 | 8.60M shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-06-28 | 8.56M shares derived: average of 2 quarters · filed 2019-06-28 | 8.50M shares 10-K · filed 2019-06-28 | |||||
| 2018-12-31 | 8.53M shares 10-Q · filed 2019-02-14 | 8.47M shares 10-Q · filed 2019-02-14 | ||||||
| 2018-03-31 | 7.20M shares 10-K · filed 2019-06-28 | 6.65M shares derived: average of 2 quarters · filed 2019-06-28 | ||||||
| 2017-12-31 | 6.10M shares 10-Q · filed 2019-02-14 | 6.13M shares 10-Q · filed 2019-02-14 | 6.00M shares 10-K · filed 2019-06-28 | |||||
| 2017-03-31 | 5.62M shares 10-KT · filed 2018-06-15 | |||||||
| 2016-12-31 | 1.45M shares 10-KT · filed 2018-06-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |